Oppenheimer CNS & Neuro-Muscular Summit
Date: June 10, 2026
Time: 7:30AM (EST)
Location: Miami Beach, FL
Senior Vice President, Traci Vitek, will be speaking on The ‘Acting’ FDA: How Current FDA Leadership Impacts the DMD/DMI and Neuropsych Regulatory Landscapes.
Oppenheimer, in collaboration with the Miami Biotech Collective is hosting the CNS & Neuro-Muscular Summit, convening biotechnology company leaders, institutional investors, key opinion leaders, patient advocates, policy experts, and market access specialists for a focused day of expert discussions, thematic panels, corporate presentations, and fireside chats.
The program highlights current developments across Duchenne muscular dystrophy, myotonic dystrophy type 1, genetic muscle disorders, psychedelic medicine, neuropsychiatry, emerging CNS therapeutics, regulatory policy, and market access.
